Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Working Opportunity Fund
investment firm
About
Working Opportunity Fund is a venture capital fund specialized in early-stage investments.
- Vancouver,British Columbia,Canada
- https://www.penderfund.com/funds/working-opportunity-fund/
Highlights
Details
- Founded date
- Jan 1, 2003
- Operating Status
- Active
- Also Known As
- PenderFund Capital Management,WOF
- Investor Type
- Venture Capital
Management of the Working Opportunity Fund transferred to PenderFund Capital on March 1, 2019
Investments
Number of Investments
Number of Lead Investments
7
1
Working Opportunity Fund has made 7 investments. Their most recent investment was on
Sep 29, 2011, when MSI Methylation Sciences raised €13.50M.
|
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|
|
Sep 29, 2011
MSI Methylation Sciences
|
Series A | €13.50M | Biotechnology | — |
|
Apr 7, 2009
Teradici
|
Series C | $17M | Enterprise Software | — |
|
Feb 14, 2007
Teradici
|
Series B | $18M | Enterprise Software | — |
|
Feb 3, 2005
GenoLogics
|
Series A | $5M | Biotechnology | — |
|
Oct 29, 2003
OncoGenex
|
Post-IPO Equity | $11.50M | Biotechnology | Yes |
Exits
Working Opportunity Fund has had 4 exits. Working Opportunity Fund most notable exits include AppNeta , Teradici
| Date | Company Name | Exit Type | Industry | |
|---|---|---|---|---|
| Dec 7, 2021 | AppNeta | M&A | Cloud Computing | Detail |
| Jul 27, 2021 | Teradici | M&A | Enterprise Software | Detail |
| Aug 4, 2015 | GenoLogics | M&A | Biotechnology | Detail |
| Oct 20, 1995 | OncoGenex | M&A | Biotechnology | Detail |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
